2023
DOI: 10.1016/j.ijid.2022.12.013
|View full text |Cite
|
Sign up to set email alerts
|

Extended-spectrum β-lactamase- and AmpC β-lactamase-producing Enterobacterales associated with urinary tract infections in the New Zealand community: a case-control study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3
2

Relationship

4
1

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 56 publications
1
3
0
Order By: Relevance
“…This present study also found that none of the putative AmpC hyperproducing isolates were MDR. This is in line with previous studies that have showed ESBLs and plasmid mediated AmpC, but not overexpressed chromosomal mediated AmpC, being associated with multidrug resistance [41,79].…”
Section: Carriage Of Esbl-/acbl-producing E Coli Within Calves and Da...supporting
confidence: 93%
See 1 more Smart Citation
“…This present study also found that none of the putative AmpC hyperproducing isolates were MDR. This is in line with previous studies that have showed ESBLs and plasmid mediated AmpC, but not overexpressed chromosomal mediated AmpC, being associated with multidrug resistance [41,79].…”
Section: Carriage Of Esbl-/acbl-producing E Coli Within Calves and Da...supporting
confidence: 93%
“…The sequence reads of other New Zealand ST10, ST69 strains as well as ST88 cattle and calf isolates previously sequenced by other institutes (Table S3) [39][40][41][42][43][44][45][46], were downloaded from the NCBI Sequence Read Archive database and processed using the Nullarbor pipeline (v. 2.0.20191013). Whole genome multi-locus sequence typing (wgMLST) was undertaken using Fast-GeP (v. 1.0) [47] and Single Nucleotide Polymorphism (SNP) analyses using Snippy (v. 4.3.6, https://github.com/tseemann/snippy).…”
Section: Genome Sequences and Bioinformaticsmentioning
confidence: 99%
“…In the current study, phylotype B2 was overrepresented in low impact sites (Figure S1 and Table S2 ), which aligns with our previous observations of its increased abundance in pristine bush environments compared to downstream sites impacted by pastoral farming (Cookson et al, 2022 ). Intriguingly, phylotype B2 has also been identified as a human‐associated E. coli phylotype, commonly isolated from urinary tract infections and associated with the extended‐spectrum beta‐lactamase resistant antibiotic resistance phenotype (Toombs‐Ruane et al, 2023 ). Therefore, we hypothesise that there are likely to be multiple pathotypes represented by phylotype B2, including those from forested sites (Petit et al, 2017 ), wildlife (Moinet et al, 2024 ) and humans with contrasting pathotype‐specific genetic characteristics (Johnson et al, 2017 ; Smati et al, 2015 ) which may influence their survival and persistence in the environment.…”
Section: Discussionmentioning
confidence: 99%
“…The ESBL enzymes confer resistance to an extended range of beta-lactam antibiotics, including the first, third and some fourth generation cephalosporins but not the cephamycins or carbapenems [7,8]. CTX-M is the predominant enzyme type associated with human clinical ESBL-producing E. coli [9][10][11]. There are more than 250 bla CTX-M gene variants, with bla CTX-M-15 being the most common amongst human clinical E. coli [12][13][14][15].…”
Section: Introductionmentioning
confidence: 99%
“…There are more than 250 bla CTX-M gene variants, with bla CTX-M-15 being the most common amongst human clinical E. coli [12][13][14][15]. The genes encoding ESBLs are often associated with other antimicrobial resistance genes (ARGs), resulting in a multidrug resistant (MDR) strain [10,11,16]. MDR pathogenic strains of Enterobacteriaceae are of particular concern to the health sector resulting in ESBL-producing Enterobacteriaceae being identified as "critical" on the World Health Organisation's "Priority Pathogens List" [17].…”
Section: Introductionmentioning
confidence: 99%